VeriSIM Life Announces Acquisition of Molomics Biotech
SAN FRANCISCO--(BUSINESS WIRE)--VeriSIM Life (VeriSIM) www.verisimlife.com, the leading Artificial Intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced the acquisition of Molomics Biotech, a privately-held drug discovery company that leverages proprietary AI te...
Comunidad Autonoma De Cataluna Dwain Schenck Jo Varshney Jascha Blobel Artificial Intelligence Molomics Biotech
Source: pharmiweb.com